A large cohort study shows that meningiomas develop years later in a significant minority of survivors, with higher risks linked to treatment at earlier ages, radiation exposure, and certain chemotherapies. Read more: https://www.emjreviews.com/neurology/news/study-tracks-risk-of-meningiomas-in-childhood-cancer-survivors/

St. Jude Children's Research Hospital scientists identified a promising combination approach to treat a rare, but catastrophic pediatric brain cancer called atypical teratoid rhabdoid tumor (ATRT). Read more: https://www.news-medical.net/news/20251216/Combination-therapy-shows-promise-to-treat-a-rare-catastrophic-pediatric-brain-cancer.aspx

Researchers at Children's Hospital of Philadelphia (CHOP) and Children's National Hospital in Washington D.C. are uncovering how rare inherited genetic variants contribute to the development of brain and spinal cord tumors in children. Read more: https://www.prnewswire.com/news-releases/researchers-highlight-genetic-factors-in-pediatric-brain-and-spinal-cord-tumors-302623472.html

Ultrasound-created microbubbles can deliver anti-cancer drugs to tumors in difficult-to-reach areas such as the brain stem and spinal cord, a pilot study in children has revealed. Read more: https://www.insideprecisionmedicine.com/topics/oncology/ultrasound-driven-microbubbles-cross-blood-brain-barrier-to-treat-childhood-cancer/

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.   Read more: https://www.curetoday.com/view/fda-grants-rare-pediatric-designation-for-iopofosine-131-in-glioma-subset

Using fruit flies, University of Wisconsin–Madison researchers have developed a new model for investigating the genetic drivers of a rare but aggressive brain tumor in children. The work has already identified potential treatment targets for the deadly cancer that has previously had few therapeutic options. Read more: https://medicalxpress.com/news/2025-10-uncover-treatment-devastating-childhood-brain.html

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing...

A collaborative study between Dana-Farber Cancer Institute and the Broad Institute found that 8.9% of children with glioma, the most...

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors...

By creating a registry of tumor-infiltrating cells, researchers are hopeful that they can develop effective and personalized treatments...